B2V327 AF NFT

Xanthine phosphoribosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifzmhpjfje3kjcgzsn2eyiyumt6iobo6rp7ody3bb6zdktaokhari/metadata.json
IPFS of structure file: 
bafybeiahyfpbjb5r3jsihmhawhdapijinwh3hfol2rqoyl5vzjpvykvbca/AF-B2V327-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9B130d619fCFc21d0D08E5Ce38Cf42A5fbe230CB
First NFT owner address (bech32): 
genesis1nvfs6cvlelpp6rgguh8r3n6z5ha7yvxthx8q26
Current NFT ID #501758 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
501758
Accession (UniProt):
B2V327
Name::
Xanthine phosphoribosyltransferase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V327 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V327|XPT_CLOBA Xanthine phosphoribosyltransferase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=xpt PE=3 SV=1 MENLHNRILEEGQALSSDVLKVDSFLNHQVDADLMYEMGTYFKNYFKDHNITKIFTIESSGIAPTVMTAMQMNLPMVILKKQGSKILKGDVYQTTVHSFTKGTDYELTLQKKYINEDDNILIIDDFLANGEAALGAARLVEGAGAKVAGIGIVIEKSFQPGPKLLEEKGYDVYSLARIEKLEKGIIKIKK